Safety

FDA cautions use of metallic tracheal stents

Ambulatory Safety Monitor, October 13, 2005

Want to receive articles like this one in your inbox? Subscribe to Ambulatory Safety Monitor!

The Food and Drug Administration (FDA) is cautioning healthcare professionals against the use of metallic tracheal stents in patients with benign airway disorders.

If used, metallic stents may cause several complications including obstructive granulation tissue, stenosis, stent migration, and infection. Removal after insertion of the stent can cause mucosal tears, severe bleeding, re-obstruction, and respiratory failure.

The FDA says metallic stents should be used only as a last resort after other options, such as silicone stents or surgical procedures, are explored.

If a metallic stent must be used, it should be inserted and, if necessary, removed by a physician trained or experienced in the use of the stent.

For additional information, click here.



Want to receive articles like this one in your inbox? Subscribe to Ambulatory Safety Monitor!

    Hospital Safety Center
  • Hospital Safety Center

    Improve compliance with hospital safety standards from The Joint Commission, OSHA, and other regulators with this...

  • Healthcare Life Safety Compliance

    Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.

  • Hospital Safety Connection

    Stay on top of hospital safety requirements and best practices with our free, fast-paced weekly update.

  • Administering Your OSHA Program

    This course will help an employee new to the role of OSHA safety officer. It gives an overview of OSHA requirements and...

  • Medical OSHA Manual Combo

    Get into compliance with Quality America's OSHA Safety Program Manual and stay in compliance with OSHA Watch Newsletter...

Most Popular

Related Articles